SecBot SecBot
Insider Cluster (3 insiders) ·Filed Sep 9, 2026

TARS

Tarsus Pharmaceuticals, Inc.
NEUTRAL
Impact 3/10
Horizondays Processed2mo ago
Insider cluster: 3 insiders, $1.3M total
Actionable Insight • Neutral

The selling is routine in size and involves multiple C-suite executives, but the lack of any insider buying and the concentration of sales near the $85-91 range warrants monitoring for any upcoming corporate events or earnings. No immediate action needed.

DirectionNeutral
Confidencehigh
Horizondays

How the stock moved after the report

NEUTRAL VIEWSTOCK BELOW ENTRY AT T+20
Entry
$81.12
T+0 close · Sep 9, 2026 · via day close
Latest settled
−10.97%
T+20 · $72.22 · next T+60 in 17d
Vs SPY
−13.35%
α at T+20
Latest observation
+4.15%
T+46 · FF3 residual α
  1. T+0 · Sep 10 $81.12entry
  2. T+1 · 2mo ago −2.23%α −3.08% · $79.31
  3. T+5 · 2mo ago −2.58%α −3.21% · $79.03
  4. T+20 · 6w ago −10.97%α −13.35% · $72.22
  5. T+47 · todayOpen
  6. T+60 · in 17d Pending
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Three top insiders (CEO, COO, CMO) sold shares totaling ~$2.5M over a one-week window ending September 4, 2026. The total represents less than 0.1% of TARS's $3.8B market cap, making this a routine cluster of insider sales with no material signal.

Key Financial Metrics

Direction
selling
Total Value
$2.5M
Insiders
3

Key Facts

  • CEO Bobak Azamian sold ~$906K worth of shares across two transactions on Sep 2 and Sep 4.
  • CMO Elizabeth Yeu sold ~$1.24M across five transactions on Sep 4.
  • COO Seshadri Neervannan sold ~$388K on Sep 4.
  • Total insider sales in the cluster: ~$2.5M, or ~0.066% of market cap.
  • No open-market purchases were reported in the cluster.

Financial Impact

Insider selling of ~$2.5M is immaterial relative to $3.8B market cap.

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
93% bullish (14 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-TARS-1789030949522

Track record

21 reports on TARS

Performance horizon

5 of 5 bullish or bearish reports moved the stock their way by T+5. Best: +27.36% at T+20 after the Aug 6, 2026 report. 5 of 5 went positive at some point.

Filters
  1. Nov 13, 20263d ago 144 Neutral 2/10 Entry $76.56 Now $78.68 +2.78% settles Nov 23
  2. Nov 5, 202611d ago 3 Neutral 2/10 Entry $68.60 to $80.28 Now $78.68 +14.69% ▲ +17.03% +14.43% vs SPY
  3. Nov 5, 202611d ago SC 13G Neutral 3/10 Entry $67.52 to $76.89 Now $78.68 +16.53% ▲ +13.88% +10.59% vs SPY
  4. Nov 3, 202613d ago 8-K Neutral 5/10 No price data
  5. Nov 3, 202613d ago Press Release Neutral 5/10 Entry $69.07 to $76.76 Now $78.68 +13.91% ▲ +11.13% +12.05% vs SPY
  6. Oct 16, 20264w ago Institutional Cluster Bullish 4/10 Entry $69.50 to $70.03 Now $78.68 +13.21% ▲ +0.76% +0.91% vs SPY
  7. Oct 13, 20264w ago S-3ASR Neutral 4/10 Entry $72.29 to $70.50 Now $78.68 +8.84% ▼ −2.48% −2.93% vs SPY
  8. Oct 13, 20264w ago S-3ASR Neutral 3/10 Entry $72.29 to $70.50 Now $78.68 +8.84% ▼ −2.48% −2.93% vs SPY
  9. Sep 9, 20269w ago Insider Cluster Neutral 3/10 Viewing Entry $81.12 to $79.03 Now $78.68 −3.01% ▼ −2.58% −3.21% vs SPY
  10. Sep 3, 202610w ago Insider Cluster Neutral 2/10 Entry $90.78 to $79.95 Now $78.68 −13.33% ▼ −11.93% −10.72% vs SPY
Showing 10 of 21

US Market Status

Market Closed · Opens in 6h 42m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Sep 10, 2026